Adjuvant Therapy With Apatinib for HCC Patients With PVTT Who Underwent Radical Resection
Status:
Unknown status
Trial end date:
2020-04-20
Target enrollment:
Participant gender:
Summary
In this phase 2 study, we aim to evaluate the effects and safety of adjuvant apatinib therapy
for the patients who underwent R0 resection for hepatocellular carcinoma with portal vein
tumor thrombus.